Are you Dr. Alzoubi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4701 Ogletown Stanton Rd
Ste 2300
Newark, DE 19713
Summary
- Dr. Ammar Alzoubi, MD is an oncologist in Newark, Delaware. He is currently licensed to practice medicine in Delaware, New York, and Minnesota. He is affiliated with ChristianaCare and Christiana Care - Wilmington Hospital.
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1998 - 2001
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1995 - 1998
University of Aleppo Faculty of MedicineClass of 1988
Certifications & Licensure
DE State Medical License 2022 - 2025
MN State Medical License 2012 - 2023
ND State Medical License 2012 - 2023
NY State Medical License 2018 - 2023
MI State Medical License 2005 - 2015
MA State Medical License 1999 - 2006
WI State Medical License 1997 - 2001- American Board of Internal Medicine Hematology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 342 citationsA phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaAndrzej Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Daniel Lebovic, David H. Vesole
Blood. 2012-08-30 - 34 citationsCarfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myelomaDominik Dytfeld, Jagoda Jasielec, Kent A. Griffith, Daniel Lebovic, David H. Vesole
Haematologica. 2014-09-01 - 64 citationsPhase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed MyelomaAndrzej Jakubowiak, Tara Kendall, Ammar Al-Zoubi, Yasser Khaled, Shin Mineishi
Journal of Clinical Oncology. 2009-10-20
Press Mentions
Sanford Health Completes North Dakota's First Bone Marrow TransplantNovember 17th, 2021
